Pregled bibliografske jedinice broj: 1111209
Role of Transmembrane Domain/Transmembrane Domain Interfaces of PGlycoprotein (ABCB1) in Solute Transport. Convergent Information from Photoaffinity Labeling, Site Directed Mutagenesis and in Silico Importance Prediction
Role of Transmembrane Domain/Transmembrane Domain Interfaces of PGlycoprotein (ABCB1) in Solute Transport. Convergent Information from Photoaffinity Labeling, Site Directed Mutagenesis and in Silico Importance Prediction // Current Medicinal Chemistry, 13 (2006), 7; 793-805 doi:10.2174/092986706776055607 (međunarodna recenzija, članak, ostalo)
CROSBI ID: 1111209 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Role of Transmembrane Domain/Transmembrane Domain
Interfaces of PGlycoprotein (ABCB1) in Solute
Transport. Convergent Information from
Photoaffinity Labeling, Site Directed Mutagenesis
and in Silico Importance Prediction
Autori
Chiba, Peter ; Mihalek, Ivana ; Ecker, Gerhard ; Kopp, Stephan ; Lichtarge, Olivier
Izvornik
Current Medicinal Chemistry (0929-8673) 13
(2006), 7;
793-805
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, ostalo
Ključne riječi
P-glycoprotein ; in silico conservation prediction ; mass spectrometry ; photoaffinity labeling ; site directed mutagenesis
Sažetak
Human P-glycoprotein (P-gp, ABCB1) plays an important role in the development of resistance to anticancer therapy. This ABC-transporter (ATP- binding cassette transporter) intercepts drugs at the level of the plasma membrane and effluxes them before they are able to reach their intracellular target structures. Inhibition of P- gp by low molecular weight compounds has been advocated as a concept for resensitization of cells to anticancer agents and several clinical studies in oncological patients have advanced to phase III. Even more importantly, P-glycoprotein also represents an antitarget. Its expression in cells lining the intestinal tract, the canalicular side of hepatocytes, renal tubuli and the blood brain barrier lead to interference with pharmacokinetics of compounds that are recognized as pump substrates. An early prediction of ADMET (Absorption-Distribution-Metabolism-Excretion- Toxicity) properties is important during drug development, since interference of a compound with P-gp might compromise its future development into a drug. Despite considerable efforts, the mechanism by which P-gp binds and transports its solutes remains unclear. Generation of homology models of the protein allowed integration of data obtained by photoaffinity labeling, in silico prediction of functional importance by evolutionary tracing and site directed mutagenesis. An integral view of data indicates that these three lines of evidence converge to indicate two pseudosymmetric P-gp drug binding pockets located at the two transmembrane domain interfaces.
Izvorni jezik
Engleski
Znanstvena područja
Biologija, Računarstvo, Interdisciplinarne biotehničke znanosti, Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE